메뉴 건너뛰기




Volumn 133, Issue 10, 2013, Pages 2454-2463

MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response

Author keywords

locally advanced esophageal cancer; microRNA pattern; neoadjuvant chemoradiation; response prediction

Indexed keywords

CISPLATIN; FLUOROURACIL; MICRORNA; MICRORNA 192; MICRORNA 194; MICRORNA 622; RNA; UNCLASSIFIED DRUG;

EID: 84883758912     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28253     Document Type: Article
Times cited : (40)

References (40)
  • 1
    • 74349113853 scopus 로고    scopus 로고
    • A novel approach to cancer staging: Application to esophageal cancer
    • Ishwaran H, Blackstone EH, Apperson-Hansen C, et al. A novel approach to cancer staging: application to esophageal cancer. Biostatistics 2009; 10: 603-20.
    • (2009) Biostatistics , vol.10 , pp. 603-620
    • Ishwaran, H.1    Blackstone, E.H.2    Apperson-Hansen, C.3
  • 2
    • 33644796262 scopus 로고    scopus 로고
    • Current and ongoing progress in the therapy for resectable esophageal cancer
    • Thomas CR, Jr,. Current and ongoing progress in the therapy for resectable esophageal cancer. Dis Esophagus 2005; 18: 211-14.
    • (2005) Dis Esophagus , vol.18 , pp. 211-214
    • Thomas, Jr.C.R.1
  • 3
    • 33847156303 scopus 로고    scopus 로고
    • Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A meta-analysis
    • Gebski V, Burmeister B, Smithers BM, et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8: 226-34.
    • (2007) Lancet Oncol , vol.8 , pp. 226-234
    • Gebski, V.1    Burmeister, B.2    Smithers, B.M.3
  • 4
    • 79959572435 scopus 로고    scopus 로고
    • Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: An updated meta-analysis
    • Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 2011; 12: 681-92.
    • (2011) Lancet Oncol , vol.12 , pp. 681-692
    • Sjoquist, K.M.1    Burmeister, B.H.2    Smithers, B.M.3
  • 5
    • 27644561794 scopus 로고    scopus 로고
    • Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: Implications for response classification
    • Schneider PM, Baldus SE, Metzger R, et al. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg 2005; 242: 684-92.
    • (2005) Ann Surg , vol.242 , pp. 684-692
    • Schneider, P.M.1    Baldus, S.E.2    Metzger, R.3
  • 6
    • 60549115069 scopus 로고    scopus 로고
    • Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis
    • Bollschweiler E, Metzger R, Drebber U, et al. Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis. Ann Oncol 2009; 20: 231-8.
    • (2009) Ann Oncol , vol.20 , pp. 231-238
    • Bollschweiler, E.1    Metzger, R.2    Drebber, U.3
  • 7
    • 78349276148 scopus 로고    scopus 로고
    • A multicenter study of survival after neoadjuvant radiotherapy/ chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer
    • Vallbohmer D, Holscher AH, DeMeester S, et al. A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg 2010; 252: 744-9.
    • (2010) Ann Surg , vol.252 , pp. 744-749
    • Vallbohmer, D.1    Holscher, A.H.2    Demeester, S.3
  • 8
    • 75149144082 scopus 로고    scopus 로고
    • Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer
    • Bollschweiler E, Holscher AH, Metzger R,. Histologic tumor type and the rate of complete response after neoadjuvant therapy for esophageal cancer. Future Oncol 2010; 6: 25-35.
    • (2010) Future Oncol , vol.6 , pp. 25-35
    • Bollschweiler, E.1    Holscher, A.H.2    Metzger, R.3
  • 9
    • 58149402944 scopus 로고    scopus 로고
    • Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer
    • Schneider PM, Metzger R, Schaefer H, et al. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer. Ann Surg 2008; 248: 902-8.
    • (2008) Ann Surg , vol.248 , pp. 902-908
    • Schneider, P.M.1    Metzger, R.2    Schaefer, H.3
  • 10
    • 33748706965 scopus 로고    scopus 로고
    • Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET
    • Sloof GW,. Response monitoring of neoadjuvant therapy using CT, EUS, and FDG-PET. Best Pract Res Clin Gastroenterol 2006; 20: 941-57.
    • (2006) Best Pract Res Clin Gastroenterol , vol.20 , pp. 941-957
    • Sloof, G.W.1
  • 11
    • 73449136130 scopus 로고    scopus 로고
    • [18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer
    • Vallbohmer D, Holscher AH, Dietlein M, et al. [18F]-Fluorodeoxyglucose- positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg 2009; 250: 888-94.
    • (2009) Ann Surg , vol.250 , pp. 888-894
    • Vallbohmer, D.1    Holscher, A.H.2    Dietlein, M.3
  • 12
    • 78751627736 scopus 로고    scopus 로고
    • Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer
    • van Heijl M, Omloo JM, van Berge Henegouwen MI, et al. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer. Ann Surg 2011; 253: 56-63.
    • (2011) Ann Surg , vol.253 , pp. 56-63
    • Van Heijl, M.1    Omloo, J.M.2    Van Berge Henegouwen, M.I.3
  • 13
    • 36348960122 scopus 로고    scopus 로고
    • Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer
    • Duong C, Greenawalt DM, Kowalczyk A, et al. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer. Ann Surg Oncol 2007; 14: 3602-9.
    • (2007) Ann Surg Oncol , vol.14 , pp. 3602-3609
    • Duong, C.1    Greenawalt, D.M.2    Kowalczyk, A.3
  • 14
    • 70449440737 scopus 로고    scopus 로고
    • Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer
    • Maher SG, Gillham CM, Duggan SP, et al. Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer. Ann Surg 2009; 250: 729-37.
    • (2009) Ann Surg , vol.250 , pp. 729-737
    • Maher, S.G.1    Gillham, C.M.2    Duggan, S.P.3
  • 15
    • 74949101064 scopus 로고    scopus 로고
    • Microarray-based response prediction in esophageal adenocarcinoma
    • Schauer M, Janssen KP, Rimkus C, et al. Microarray-based response prediction in esophageal adenocarcinoma. Clin Cancer Res 2010; 16: 330-7.
    • (2010) Clin Cancer Res , vol.16 , pp. 330-337
    • Schauer, M.1    Janssen, K.P.2    Rimkus, C.3
  • 16
    • 84876718945 scopus 로고    scopus 로고
    • MicroRNAs and esophageal cancer - Implications for pathogenesis and therapy
    • Mayne GC, Hussey DJ, Watson DI,. microRNAs and esophageal cancer-implications for pathogenesis and therapy. Curr Pharm Des 2013; 19: 1211-26.
    • (2013) Curr Pharm des , vol.19 , pp. 1211-1226
    • Mayne, G.C.1    Hussey, D.J.2    Watson, D.I.3
  • 17
    • 67349106718 scopus 로고    scopus 로고
    • Small RNA: A large contributor to carcinogenesis?
    • Bhatti I, Lee A, Lund J, et al. Small RNA: a large contributor to carcinogenesis? J Gastrointest Surg 2009; 13: 1379-88.
    • (2009) J Gastrointest Surg , vol.13 , pp. 1379-1388
    • Bhatti, I.1    Lee, A.2    Lund, J.3
  • 18
    • 39149100654 scopus 로고    scopus 로고
    • Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma
    • Guo Y, Chen Z, Zhang L, et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 26-33.
    • (2008) Cancer Res , vol.68 , pp. 26-33
    • Guo, Y.1    Chen, Z.2    Zhang, L.3
  • 19
    • 78349253777 scopus 로고    scopus 로고
    • Prognostic significance of differentially expressed miRNAs in esophageal cancer
    • Hu Y, Correa AM, Hoque A, et al. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 2011; 128: 132-43.
    • (2011) Int J Cancer , vol.128 , pp. 132-143
    • Hu, Y.1    Correa, A.M.2    Hoque, A.3
  • 20
    • 70349662168 scopus 로고    scopus 로고
    • MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: Associations with survival
    • Mathe EA, Nguyen GH, Bowman ED, et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009; 15: 6192-200.
    • (2009) Clin Cancer Res , vol.15 , pp. 6192-6200
    • Mathe, E.A.1    Nguyen, G.H.2    Bowman, E.D.3
  • 21
    • 67650664984 scopus 로고    scopus 로고
    • Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR
    • Ogawa R, Ishiguro H, Kuwabara Y, et al. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol 2009; 42: 102-9.
    • (2009) Med Mol Morphol , vol.42 , pp. 102-109
    • Ogawa, R.1    Ishiguro, H.2    Kuwabara, Y.3
  • 22
    • 33846258745 scopus 로고    scopus 로고
    • RNASEN regulates cell proliferation and affects survival in esophageal cancer patients
    • Sugito N, Ishiguro H, Kuwabara Y, et al. RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res 2006; 12: 7322-8.
    • (2006) Clin Cancer Res , vol.12 , pp. 7322-7328
    • Sugito, N.1    Ishiguro, H.2    Kuwabara, Y.3
  • 23
    • 80052971458 scopus 로고    scopus 로고
    • Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma
    • Akagi I, Miyashita M, Ishibashi O, et al. Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. Dis Esophagus 2011; 24: 523-30.
    • (2011) Dis Esophagus , vol.24 , pp. 523-530
    • Akagi, I.1    Miyashita, M.2    Ishibashi, O.3
  • 24
    • 79955375953 scopus 로고    scopus 로고
    • MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma
    • Feber A, Xi L, Pennathur A, et al. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann Thorac Surg 2011; 91: 1523-30.
    • (2011) Ann Thorac Surg , vol.91 , pp. 1523-1530
    • Feber, A.1    Xi, L.2    Pennathur, A.3
  • 25
    • 78651356009 scopus 로고    scopus 로고
    • MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma
    • Hummel R, Hussey DJ, Michael MZ, et al. MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann Surg Oncol 2011; 18: 253-60.
    • (2011) Ann Surg Oncol , vol.18 , pp. 253-260
    • Hummel, R.1    Hussey, D.J.2    Michael, M.Z.3
  • 26
    • 78651507625 scopus 로고    scopus 로고
    • MiRNA profile in esophageal squamous cell carcinoma: Downregulation of miR-143 and miR-145
    • Wu BL, Xu LY, Du ZP, et al. MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World J Gastroenterol 2011; 17: 79-88.
    • (2011) World J Gastroenterol , vol.17 , pp. 79-88
    • Wu, B.L.1    Xu, L.Y.2    Du, Z.P.3
  • 27
    • 79955519053 scopus 로고    scopus 로고
    • Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway
    • Hamano R, Miyata H, Yamasaki M, et al. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin Cancer Res 2011; 17: 3029-38.
    • (2011) Clin Cancer Res , vol.17 , pp. 3029-3038
    • Hamano, R.1    Miyata, H.2    Yamasaki, M.3
  • 28
    • 77953020454 scopus 로고    scopus 로고
    • The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma
    • Hong L, Han Y, Zhang H, et al. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 2010; 251: 1056-63.
    • (2010) Ann Surg , vol.251 , pp. 1056-1063
    • Hong, L.1    Han, Y.2    Zhang, H.3
  • 29
    • 79960781245 scopus 로고    scopus 로고
    • Chemotherapy-induced modification of microRNA expression in esophageal cancer
    • Hummel R, Wang T, Watson DI, et al. Chemotherapy-induced modification of microRNA expression in esophageal cancer. Oncol Rep 2011; 26: 1011-17.
    • (2011) Oncol Rep , vol.26 , pp. 1011-1017
    • Hummel, R.1    Wang, T.2    Watson, D.I.3
  • 30
    • 84866670215 scopus 로고    scopus 로고
    • MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy
    • Ko MA, Zehong G, Virtanen C, et al. MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy. Ann Thorac Surg 2012; 94: 1094-102.
    • (2012) Ann Thorac Surg , vol.94 , pp. 1094-1102
    • Ko, M.A.1    Zehong, G.2    Virtanen, C.3
  • 32
    • 33846426446 scopus 로고    scopus 로고
    • Laparoscopic ischemic conditioning of the stomach for esophageal replacement
    • Holscher AH, Schneider PM, Gutschow C, et al. Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Ann Surg 2007; 245: 241-6.
    • (2007) Ann Surg , vol.245 , pp. 241-246
    • Holscher, A.H.1    Schneider, P.M.2    Gutschow, C.3
  • 33
    • 77952424611 scopus 로고    scopus 로고
    • Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit
    • Schroder W, Holscher AH, Bludau M, et al. Ivor-Lewis esophagectomy with and without laparoscopic conditioning of the gastric conduit. World J Surg 2010; 34: 738-43.
    • (2010) World J Surg , vol.34 , pp. 738-743
    • Schroder, W.1    Holscher, A.H.2    Bludau, M.3
  • 34
    • 58349108273 scopus 로고    scopus 로고
    • Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR
    • Siebolts U, Varnholt H, Drebber U, et al. Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR. J Clin Pathol 2009; 62: 84-8.
    • (2009) J Clin Pathol , vol.62 , pp. 84-88
    • Siebolts, U.1    Varnholt, H.2    Drebber, U.3
  • 35
    • 0027457620 scopus 로고
    • Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine
    • Zweig MH, Campbell G,. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77.
    • (1993) Clin Chem , vol.39 , pp. 561-577
    • Zweig, M.H.1    Campbell, G.2
  • 36
    • 79952067801 scopus 로고    scopus 로고
    • Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells
    • Hummel R, Watson DI, Smith C, et al. Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. J Gastrointest Surg 2011; 15: 429-38.
    • (2011) J Gastrointest Surg , vol.15 , pp. 429-438
    • Hummel, R.1    Watson, D.I.2    Smith, C.3
  • 37
    • 84875821441 scopus 로고    scopus 로고
    • MicroRNA-145 in Barrett's oesophagus: Regulating BMP4 signalling via GATA6
    • van Baal J, Verbeek R, Bus P, et al. microRNA-145 in Barrett's oesophagus: regulating BMP4 signalling via GATA6. Gut 2013; 62: 664-75.
    • (2013) Gut , vol.62 , pp. 664-675
    • Van Baal, J.1    Verbeek, R.2    Bus, P.3
  • 38
    • 58149340662 scopus 로고    scopus 로고
    • MiR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit
    • Song B, Wang Y, Kudo K, et al. miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res 2008; 14: 8080-6.
    • (2008) Clin Cancer Res , vol.14 , pp. 8080-8086
    • Song, B.1    Wang, Y.2    Kudo, K.3
  • 39
    • 77955478900 scopus 로고    scopus 로고
    • MiR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation
    • Boni V, Bitarte N, Cristobal I, et al. miR-192/miR-215 influence 5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation. Mol Cancer Ther 2010; 9: 2265-75.
    • (2010) Mol Cancer Ther , vol.9 , pp. 2265-2275
    • Boni, V.1    Bitarte, N.2    Cristobal, I.3
  • 40
    • 84859460629 scopus 로고    scopus 로고
    • MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response
    • Wang W, Corrigan-Cummins M, Hudson J, et al. MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica 2012; 97: 586-94.
    • (2012) Haematologica , vol.97 , pp. 586-594
    • Wang, W.1    Corrigan-Cummins, M.2    Hudson, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.